Ani pharmaceuticals says making progress to address items identified in fda's refusal to file letter relating to cortrophin gel snda filing

Ani pharmaceuticals - continues to make progress to address items identified in fda's refusal to file letter relating to cortrophin gel snda filing.ani pharmaceuticals - plans on refiling snda for cortrophin gel with fda upon completion of review process.

ANIP Ratings Summary

ANIP Quant Ranking